Results for this period
Interim period (second quarter)1 April 2026 to 30 September 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Operating revenue increased due to growth in existing-store sales, new store openings, the expansion of the drugstore network and the contribution from ドミー following its consolidation. Operating profit and ordinary profit declined due to increases in personnel expenses, facility expenses related to new store openings, sales commissions and interest expenses. Interim net income attributable to owners of the parent increased due to special gains, including a gain on the revision of the retirement benefit plan.
No applicable matters. The notes on going concern state, “Not applicable.”
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 September 2026 |
| Net Sales | ¥489,204 million (YoY +8.6%) |
| Operating profit | ¥12,564 million (YoY -10.6%) |
| Ordinary income | ¥13,679 million (YoY -9.3%) |
| Profit attributable to owners of the parent | ¥9,483 million (YoY +14.6%) |
| Net income per share | ¥86.43 |
| Operating Margin | 2.6% |
| Equity ratio | End of the current fiscal period 39.2% / End of previous period 35.9% |
| Total assets | ¥535,424 million |
| Net assets | ¥228,558 million |
| Cash flows from operating activities | ¥13,836 million |
| Cash flows from investing activities | ¥-23,841 million |
| Cash flows from financing activities | ¥10,523 million |
| Cash and cash equivalents at end of period | ¥32,272 million |
| Full-year earnings forecast | Net Sales ¥1,000,000 million (YoY +8.2%) / Operating profit ¥28,000 million (YoY +1.5%) / Ordinary income ¥30,500 million (YoY +1.6%) / Net income ¥16,500 million (YoY +0.1%) |
| Revision to Earnings Forecast | No revision |
| Annual Dividend Forecast | ¥74 per share → — (annual total after adjustment for stock split; ¥80 before the split)（Approximately 8.1% (before adjustment for stock split)） |
| Segment revenue | Supermarket business ¥291,393 million (YoY +13.6%) / Drugstore Business ¥94,575 million (YoY +2.3%) / Home-Center Business ¥63,524 million (YoY -2.4%) / Pet shop business ¥18,957 million (YoY +7.0%) / Sports Club Business ¥6,059 million (YoY +8.2%) / Distribution-related business ¥11,417 million (YoY +9.1%) / Other Businesses ¥3,276 million (YoY +24.8%) |
| Segment profit | Supermarket business ¥9,910 million (YoY -4.7%) / Drugstore Business ¥1,260 million (YoY -20.5%) / Home-Center Business ¥2,455 million (YoY -26.2%) / Pet shop business ¥313 million (YoY -17.6%) / Sports Club Business ¥237 million (YoY +313.8%) / Distribution-related business ¥2,609 million (YoY +11.1%) / Other Businesses ¥75 million (YoY -25.1%) |
| Depreciation and amortization | ¥13,056 million |
| Impairment loss | ¥82 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥229 million / Gain on sale of investment securities ¥248 million / Penalty Income ¥48 million / Gain on revision of retirement benefit plans ¥2,281 million / Other ¥19 million / Total ¥2,827 million / Extraordinary loss Loss on sale of non-current assets ¥2 million / Loss on Disposal of Fixed Assets ¥69 million / Impairment loss ¥82 million / Other ¥5 million / Total ¥159 million |
| Disclosure regarding the going concern assumption | No applicable matters. The notes on going concern state, “Not applicable.” |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 / Excluded 0 / Company name None |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Yes (for securities analysts and institutional investors) |
| Issued Shares at Period-End | 118,772,398 |
| Treasury Shares at Period-End | 2,611,222 |
| Factors Behind Changes in Business Performance | Operating revenue increased due to growth in existing-store sales, new store openings, the expansion of the drugstore network and the contribution from ドミー following its consolidation. Operating profit and ordinary profit declined due to increases in personnel expenses, facility expenses related to new store openings, sales commissions and interest expenses. Interim net income attributable to owners of the parent increased due to special gains, including a gain on the revision of the retirement benefit plan. |
Items this document does not state (5)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Operating revenue increased due to growth in existing-store sales in the core supermarket business, new store openings, the expansion of the drugstore business's store network and the contribution from the operating revenue of ドミー, which became a consolidated subsidiary in the previous fiscal year. Operating profit and ordinary profit declined due to increases in personnel expenses, facility expenses associated with new store openings and other activities, sales commissions and interest expenses resulting from higher interest rates. Interim net income attributable to owners of the parent increased due to special gains, including a gain on the revision of the retirement benefit plan.